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Some patients with coronavirus disease (COVID-19) present with severe acute respiratory syndrome, which
causes multiple organ dysfunction, besides dysfunction of the respiratory system, that requires invasive
procedures. On the basis of the opinions of front-line experts and a review of the relevant literature on several
topics, we proposed clinical practice recommendations on the following aspects for physiotherapists facing
challenges in treating patients and containing virus spread: 1. personal protective equipment, 2. conventional
chest physiotherapy, 3. exercise and early mobilization, 4. oxygen therapy, 5. nebulizer treatment, 6. non-
invasive ventilation and high-flow nasal oxygen, 7. endotracheal intubation, 8. protective mechanical ven-
tilation, 9. management of mechanical ventilation in severe and refractory cases of hypoxemia, 10. prone
positioning, 11. cuff pressure, 12. tube and nasotracheal suction, 13. humidifier use for ventilated patients, 14.
methods of weaning ventilated patients and extubation, and 15. equipment and hand hygiene. These recom-
mendations can serve as clinical practice guidelines for physiotherapists. This article details the development of
guidelines on these aspects for physiotherapy of patients with COVID-19.
KEYWORDS: COVID-19; Physiotherapy; Mechanical Ventilation; Oxygen Therapy; Severe Acute Respiratory
Syndrome Coronavirus 2.
’ INTRODUCTION
The current outbreak of coronavirus disease 2019 (COVID-
19) originated in the Hubei Province of the People’s Repub-
lic of China (1,2), and on March 11, 2020, it was declared a
pandemic by the World Health Organization Emergency
Committee (2).
The most common symptoms include fever (89%), cough
(68%), fatigue (38%), sputum production (34%), and short-
ness of breath (19%) (3). A considerable proportion of the
population with COVID-19 will not require hospitalization
as the patients present a mild or uncomplicated form of the
disease with a favorable prognosis. However, older patients
and those with chronic underlying conditions can develop
severe illness and present complications such as acute
respiratory disease syndrome (ARDS), sepsis, septic shock,
and kidney and cardiac failure, which require treatment in an
intensive care unit (ICU) with invasive support (4).
Approximately 14% of patients develop a severe form of
COVID-19, requiring hospitalization, and 5% require admis-
sion to an ICU (5).
Physiotherapists are recognized in several countries as
professionals working in primary and tertiary care (6-8) who
play a fundamental role in multi-professional teams provid-
ing ventilatory support during the acute illness phase and
rehabilitation interventions thereafter to promote function-
ality (9,10).
This paper describes the different actions and practices
adopted by the Rehabilitation Service of Hospital Sírio-
Libanês (São Paulo, Brazil) to face the challenges in treating
and containing the spread of COVID-19. Issues pertaining to
clinical practice in the adult hospital setting were identified
on the basis of the experience and opinions of front-line
experts as well as a review of the relevant literature.
To provide the maximum level of care and ensure staff
protection, recommendations were developed regarding
protective equipment, conventional chest physiotherapy,
exercise and early mobilization, oxygen therapy, nebulizer
treatment, non-invasive ventilation and high-flow nasal
oxygen, endotracheal intubation, protective mechanical
ventilation, management of mechanical ventilation in severe
and refractory cases of hypoxemia, prone positioning, cuff
pressure, tube and nasotracheal suction, humidifier use for
ventilated patients, methods of weaning ventilated patients,
and equipment and hand hygiene.DOI: 10.6061/clinics/2020/e2017
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’ PERSONAL PROTECTIVE EQUIPMENT (PPE)
Several procedures performed by physiotherapists may
generate aerosols and droplets, which are sources of lung
and respiratory pathogens. These procedures include non-
invasive ventilation, high-flow oxygenation, endotracheal
intubation, airway tracheostomy and endotracheal tube
suction, cardiopulmonary resuscitation, high-frequency oscil-
latory ventilation, chest physiotherapy, prone patient posi-
tioning, disconnection of the ventilator, administration of
nebulized treatment, and sputum induction (11-14). Fur-
thermore, severe acute respiratory syndrome coronavirus 2
can remain in the air for hours and on surfaces of various
materials for days upon aerosolization, with risks of
possible human infection (15). However, when aerosol-
generating procedures cannot be avoided, they should be
performed in a negative-pressure room. In the absence of
negative-pressure rooms, the procedures must be per-
formed in a room with closed doors and open windows;
with minimum number of qualified professionals to per-
form the procedures; with appropriate PPE; and avoiding
the presence other people (16,17). Therefore, physiothera-
pists must adopt protective measures to avoid aerosol
exposure and for contact isolation by using adequate PPE,
namely, surgical caps, safety goggles, face shields, N95
masks or equivalent, gowns, and gloves (17-19).
’ CONVENTIONAL CHEST PHYSIOTHERAPY
Currently, no evidence exists indicating that conventional
chest physiotherapy changes the course of COVID-19 in
the acute phase of the disease in patients with hypoxemic
respiratory failure and dry cough. However, some patients
with productive cough may benefit from bronchial hygiene
maneuvers and techniques that stimulate coughing (20,21).
Patients with a mild form of the disease should be instructed
to perform breathing exercises independently. Patients with
moderate and severe conditions should be constantly
monitored for pulmonary disease (22). In these cases, phy-
siotherapists should contact the patient only for respiratory
and pulmonary assessments, especially during orotracheal
intubation and oxygen supplementation and for patients
who are candidates for non-invasive ventilation or high-flow
oxygen administration (22,23). The professional exposure
time should be the minimum necessary for evaluation and
assistance (22,24).
’ EXERCISE AND EARLY MOBILIZATION
Patients usually present with a debilitated physical con-
dition because of the disease, which reduces their exercise
capacity, especially when they present with fever, dyspnea,
myalgia, and fatigue (20); the debilitated physical condi-
tion can also be a result of prolonged mechanical ventilation
and immobilization. Hospitalized patients, even those with
moderate disease severity, can spend weeks in hospital
isolation, with a significant decrease in their activity levels,
and are thus prone to a reduction in their muscle strength
and cardiorespiratory capacity (25). Therefore, patients in the
acute phase with mild disease should be encouraged to
perform light-intensity exercises to maintain minimal func-
tional capacity. The exercises can be tailored for maintenance
of a Borg rating of o3 (on a 10-point scale) (22). Although
there are no studies specific to patients with COVID-19,
classically critical patients who underwent early mobiliza-
tion showed a reduction in delirium and duration of mecha-
nical ventilation (26); thus, early mobilization should be
started as soon as possible, as long as the patient presents
suitable clinical conditions (27). This mobilization can include
neuromuscular stimulation, therapeutic exercises, and early
verticalization (28-31).
’ OXYGEN THERAPY
The prevalence of hypoxic respiratory failure in adults
with COVID-19 is 19%; thus, oxygen therapy represents a
major treatment intervention for patients with severe pul-
monary dysfunction (2,32). Adults with COVID-19 should be
started on supplemental oxygen if the peripheral oxygen
saturation (SpO2) is o93% and maintained oxygen satura-
tion is no higher than 96% (23). Mechanical ventilation may
be necessary in cases of respiratory failure refractory to
oxygen therapy (2,23).
The interfaces used for oxygen supplementation can
generate aerosols. Therefore, health care workers should
take adequate precautions and wear proper PPE when
providing respiratory support to patients with COVID-19
complicated by respiratory failure (19,33). Oxygen humidi-
fication should not be used (34). The prescription of
moisturizers such as self-applied nasal sodium chloride
gel may be suggested for complications such as dryness of
the upper airways or epistaxis. The oxygen supply device
should be changed if these complications persist.
Figure 1 shows our institutional proposal for oxygen
therapy and early transfer to the ICU for patients with respi-
ratory distress and hypoxemia on the basis of the Surviving
Sepsis Campaign: Guidelines on the Management of Criti-
cally Ill Adults with Coronavirus Disease 2019 (COVID-19).
’ NEBULIZER TREATMENT
All forms of nebulization (including inhalation) are
potential aerosol generators and should be avoided (2,35).
Bronchodilators should be administered with metering units
(puff or spray) in an air chamber/spacer (2).
’ NON-INVASIVE VENTILATION AND HIGH-FLOW
NASAL OXYGEN
For the treatment of acute hypoxemic respiratory failure,
the use of high-flow nasal oxygen is suggested over
conventional oxygen therapy and non-invasive positive
pressure ventilation (36-38). If high-flow nasal oxygen is
not available, a trial of non-invasive ventilation is suggested
(39). An experiment in a human model showed that non-
invasive ventilation or high-flow nasal oxygen, when well
applied with an optimal fit, resulted in minimal aerosoliza-
tion of exhaled air (40). However, the specific models of
masks and interfaces tested in the study are not universally
used in all hospitals. Therefore, to avoid potential harm, we
recommend using adequate precautions and PPE and
discourage the use of this procedure if an airborne infection
isolation room is unavailable (2,16). Monitoring for worsen-
ing respiratory status and subsequent early intubation is
recommended (39).
Patient candidates for non-invasive ventilation admitted to
the ICU in negative-pressure rooms must be ventilated with
positive end-expiratory pressure (PEEP) X8 cmH2O, support
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pressure for a tidal volume (TV) p8 mL/kg of the predicted
weight, and fraction of inspired oxygen (FiO2) to maintain
SaO2 492%. Facial or full-face masks must be used during
application of the ventilator. Devices with double branches
for ventilation are indicated in these cases, with a heat
moisture exchange filter (HMEF) between the face mask and
the device and another high-efficiency particulate arrestance
(HEPA) filter on the exhalation outlet of the ventilator. For
high-flow oxygen, a flow rate of 40 to 50 L/min should be
maintained, and FiO2 to maintain SaO2492% should be started.
Figure 1 - Proposal for oxygen therapy and early transfer to intensive care units for patients with respiratory distress and hypoxemia
based on Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).
SaO2: arterial oxygen saturation; ICU: intensive care unit; PPE: Personal protective equipment; NIV: non-invasive ventilation; HFNO:
high-flow nasal oxygen.
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The criteria for orotracheal intubation and invasive mecha-
nical ventilation are FiO2 460% in non-invasive ventila-
tion or TV X9 mL/kg or inability to tolerate o2 hours
without non-invasive ventilation or presence of other organic
dysfunctions. For high-flow oxygen, the criteria for orotra-
cheal intubation are FiO2 460% or signs of respiratory distress,
or other organic dysfunctions. It is important to reassess the
patient after 30 to 60 minutes; if there is no improvement or if
there is worsening of ventilatory parameters, endotracheal
intubation and invasive mechanical ventilation should be
considered (Figure 2) (2,23,36-38).
’ ENDOTRACHEAL INTUBATION
When aerosol-generating procedures are required, they are
recommended to be performed in a negative-pressure room
and with the use of appropriate PPE (16). Only the profes-
sionals needed to perform orotracheal intubation should
remain in the room.
Patients with COVID-19 are at risk of a rapid decrease
in arterial oxygen levels; therefore, effective pre-oxygenation
is mandatory. Patients must be administered a sufficient
oxygen flow to maintain SpO2 493%, and intubation should
be performed with a rapid sequence of induction and intu-
bation. Pre-oxygenation with a non-rebreather mask with the
lowest possible airflow to maintain effective oxygenation
(SpO2 493%) (41) is required. It is also important to avoid
assisted ventilation with the Bag-Valve-Mask device or the
use of a supraglottic device because of the potential for
aerosolization and contamination of health workers. How-
ever, if necessary, we suggest adding a filter between the
simple respirator and the Bag-Valve-Mask or artificial airway
during use (Figure 3) to reduce the spread of the virus in the
patient’s airway to the indoor air (19).
After orotracheal intubation, checking the proper posi-
tioning of the orotracheal tube and inflating the cuff are
recommended. The patient can then be connected to the
ventilator associated with the HMEF and with a HEPA filter
in the expiratory valve of the mechanical ventilator. These
filters can filter bacteria and viruses and reduce room conta-
mination (2,41-43). Airway interventions must be carried out
by experienced individuals. After each procedure, appro-
priate hand hygiene is required (41).
’ PROTECTIVE MECHANICAL VENTILATION
Invasive mechanical mode volume-controlled ventilation
(in the presence of neuromuscular block or the absence of
Figure 2 - Proposal for non-invasive ventilation and high-flow nasal oxygen for patients with COVID-19. NIV: non-invasive ventilation;
EPAP: expiratory positive airway pressure; IPAP: inspiratory positive airway pressure; TV: tidal volume; FiO2: fraction of inspired oxygen;
HFNO: high-flow nasal oxygen; SaO2: arterial oxygen saturation.
Figure 3 - Bag-Valve-Mask device: (A) face mask, (B) heat
moisture exchange filter, and (C) Bag-Valve-Mask.
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inspiratory effort) or pressure-controlled ventilation (in the
absence of neuromuscular block and mild respiratory effort
and asynchrony) should be performed with lower TVs
(4 to 6 mL/kg predicted body weight) and lower inspira-
tory pressures, reaching a plateau pressure (Pplat) of o28-
30 cmH2O (44). The PEEP must be as high as possible to
maintain the driving pressure (Pplat  PEEP) as low as
possible (o15 cmH2O) and SpO2 88-95% (44,45). Moreover,
disconnection from the invasive mechanical ventilator must be
avoided to prevent loss of PEEP and consequent atelectasis.
’ MANAGEMENT OF MECHANICAL VENTILATION
IN SEVERE AND REFRACTORY CASES OF
HYPOXEMIA
For patients with PaO2/FiO2 o150 and an inability to
maintain protective ventilation or with the presence of
asynchrony or severe hypercapnia (pH o7.25), we suggest
sedation and continuous neuromuscular block to reduce
respiratory drive and maintain protective ventilation. The
multidisciplinary team can discuss the following: 1. prone
positioning; 2. alveolar recruitment maneuvers and PEEP
adjustment for better pulmonary compliance; 3. recruitment
in the prone position for patients who responded to the
supine recruitment maneuver; 4. nitric oxide administration
in cases with a clinical history of ‘‘cor pulmonale’’ or as a
recruitment maneuver for hypoxemia; and 5. extracorporeal
membrane oxygenation (ECMO) (2,44,46,47).
’ PRONE POSITION
Prone ventilation for 12 to 16 hours a day is recommended
in adult patients with severe ARDS (PaO2/FiO2 o150),
(2,44). It is strongly recommended for adult patients with
severe ARDS but requires sufficient human resources and
knowledge to be performed safely. Protocols and videos are
available in the study by Guérin et al., 2013. A satisfactory
response is defined as a patient achieving an increase of
10 mmHg in PaO2 or an increase of 20 mmHg in the PaO2/
FiO2 ratio. Prone positioning should be repeated when a
PaO2/FiO2 ratio o150 mmHg is observed after 6 hours in
the supine position. PaO2/FiO2 reductions of 20% in the
supine position should be considered criteria for interrupting
the prone position after two consecutive attempts at prona-
tion or hemodynamic instability (48,49).
’ CUFF PRESSURE
Invasive mechanical ventilation is a risk factor for aerosols
(50). Therefore, it is important to maintain a cuff pres-
sure between 20 and 30 cmH2O or 25 and 35 mmHg, with
sufficient pressure to prevent leakage and aerosol spread
(51). We suggest cuff measurement either at every shift or at
least daily (51).
’ TUBE AND NASOTRACHEAL SUCTION
Suction of the artificial airway because of ventilator dis-
connection must be avoided so that there is no loss of
pressure in the respiratory system, atelectasis, or spread of
aerosols in the room. The use of a closed suction system in all
cases of intubation and invasive mechanical ventilation is
recommended (2,50). In situations requiring open suction,
we suggest the use of the ‘‘stand by’’ mode of the mechanical
ventilator to minimize the spread of aerosols. Nasotracheal
suction should be performed with careful evaluation by
the physiotherapist because of the generation of aerosols.
To perform these procedures, the use of proper PPE is
recommended. Whenever possible, this procedure should be
performed in a negative-pressure room.
’ HUMIDIFIERS FOR VENTILATED PATIENTS
Heat and moisture exchangers or heated humidifiers are
more effective in preventing complications such as airway
blockages and pneumonia in adults who receive invasive
mechanical ventilation (52). Therefore, patients with COVID-
19 should use devices that humidify and filter their inhaled
and exhaled air, respectively. Thus, HMEF is more suitable
for the humidification of exchanged air as it also has filtering
capacity for viruses and bacteria, thus reducing air contam-
ination. Additional protection can be provided by placing
a HEPA filter on the exhalation valve of the mechanical
ventilator. The use of heated humidifiers is discouraged in
these patients (43).
’ WEANING FROM MECHANICAL VENTILATION
AND EXTUBATION
All patients must be evaluated daily regarding the
eligibility criteria for the spontaneous breathing test,
considering adequate oxygenation: PaO2/FiO24200 with
PEEP p5-7 cmH2O, hemodynamic stability with low and
stabilized doses or without vasopressor drug infusion, an
adequate level of consciousness (easily awake or wakened),
and adequate cough and secretion management with the
presence of a cough reflex during closed aspiration (53,54).
To wean patients with COVID-19 from mechanical
invasive ventilation, we recommend the use of the pressure
support ventilation (PSV) mode for spontaneous breathing
tests. The use of the T-tube method should be avoided as it
can increase aerosolization (43). Table 1 shows the para-
meters suggested for the spontaneous breathing test in PSV
(A), success criteria (B), and failure criteria (C) (55-60). The
cuff leak test should not be performed routinely before
extubation because of the risk of aerosolization. However,
its use should be considered for the clinical suspicion of
upper airway edema or the presence of risk factors for post-
extubation stridor (61).
Patients who pass the spontaneous breathing test should
preferably be extubated in a negative-pressure room or in
respiratory isolation. Physiotherapists and other health profes-
sionals present in the environment during extubation must
follow PPE aerosol isolation precautions. During the proce-
dure, extra care must be taken during extubation, including
keeping the HMEF and closed endotracheal suction (e. g.
Trach-Cares) connected to the endotracheal tube when
deflating the cuff. The endotracheal tube should be removed
as gently as possible to avoid vigorous manipulation and
coughing. If it is necessary to stimulate the patient’s cough,
the patient should be instructed to adopt cough etiquette.
The tube must be discarded in the infectious waste collector. In
the ICU, the availability of a professional with experience in
intubation is always recommended during the extubation of
patients diagnosed with COVID-19, in case rapid reintubation
is necessary. The rate of reintubation of these patients should
be as low as possible; therefore, we recommend that the
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decision regarding the patient’s extubation be rigorously
discussed within the multidisciplinary team (62,63).
Tracheostomy may be indicated for patients who con-
secutively fail to wean or with long periods of intubation.
Tracheostomy is considered a high-risk procedure for the
formation of aerosols. Weaning patients using tracheostomy
masks (e.g., Trach-Vents and T-tube) is not recommended
for patients with COVID-19. Rather, for spontaneous breath-
ing training periods, the use of HMEF connected to Trach-
Cares (Figure 4), with oxygen supplementation directly in
the HMEF to maintain SpO2 between 93 and 96%, is recom-
mended. If aspiration is required during the spontaneous
breathing test, the closed suction system must be used. We
emphasize that the use of HMEF to wean tracheostomized
patients requires constant assessment of clinical signs of
discomfort or instability. Spontaneous breathing time should
be progressive as patients improve breathing performance
and resistance (64).
’ EQUIPMENT AND HAND HYGIENE
The cleaning of the equipment with 70% alcohol or
chlorine-based substances is recommended immediately
after use. Health workers should wash their hands fre-
quently, especially after contact with infected people or their
environment (2).
’ CONCLUSION
COVID-19 is a new disease that presents challenges to
inpatient care. These recommendations can serve as clinical
practice guidelines for physiotherapists. Physiotherapy plays
a fundamental role throughout patient hospitalization.
However, the hospital physiotherapy team must be well-
oriented regarding specific care to both reduce infection risk
and provide the best patient care. The Appendix section
presents cards from our institution, Hospital Sírio-Libanês, in
English and Portuguese languages for the respiratory man-
agement of patients with suspected or confirmed COVID-19
infection.
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